Creative Medical Technology Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.03.24	Creative Medical Announces FDA Authorization For Expanded Access For CELZ-201; Stock Up (RTTNews)
06.03.24	Creative Medical Receives FDA Orphan Drug Designation For CELZ-101; Stock Up In Pre-market (RTTNews)
15.11.23	Creative Medical Technology Holdings Provides Corporate Update (PR Newswire)
10.10.23	Creative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy (RTTNews)
10.10.23	Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain (PR Newswire)
19.09.23	Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain (PR Newswire)
28.07.23	Pre-market Movers: SIGA, SNBR, BLUA, SNTG, PRZO… (RTTNews)
29.06.23	Pre-market Movers: SGTX, WAVE, BTAI, KTRA, CRMD… (RTTNews)
28.06.23	Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements (PR Newswire)
16.06.23	Pre-market Movers: SPCE, IRBT, BMR, COMS, FNGR… (RTTNews)
12.06.23	Creative Medical Technology Announces $2 Million Share Repurchase Program (PR Newswire)
12.06.23	Creative Medical Technology Holdings Provides Corporate Update (PR Newswire)
09.06.23	Creative Medical Technology Holdings Announces Reverse Stock Split (PR Newswire)
31.05.23	Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immun... (PR Newswire)
22.05.23	Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development (PR Newswire)
18.05.23	Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line (PR Newswire)
12.04.23	Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study (PR Newswire)
04.04.23	Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update (PR Newswire)
23.03.23	Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes (PR Newswire)
21.03.23	Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development (PR Newswire)
08.02.23	Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes (PR Newswire)
03.11.22	Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes (PR Newswire)
20.10.22	Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line (PR Newswire)
26.09.22	Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study (PR Newswire)
28.07.22	Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study (PR Newswire)
15.06.22	Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform (PR Newswire)
29.04.22	Creative Medical Technology Announces $17 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire)
20.04.22	Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company's ImmCelz® Product (PR Newswire)
12.04.22	Creative Medical Technology to Showcase CaverStem® at American Urological Association Annual Meeting - Largest and Most Prominent Gathering of Urologists in the World (PR Newswire)
31.03.22	Creative Medical Technology Signs Master Collaboration Agreement with the University of Miami to Accelerate Development of ImmCelz® Supercharged Autologous Immunotherapy Platform (PR Newswire)
23.03.22	Creative Medical Technology Announces Positive Top-Line Results for StemSpine® Pilot Study (PR Newswire)
10.03.22	Creative Medical Technology Secures Exclusive Distribution Rights for Cervos Medical's Marrow Cellution™ Devices for Use in Urology, Gynecology, and Male and Female Sexual Dysfunction (PR Newswire)
08.03.22	Creative Medical Technology to Participate in the 34th Annual Roth Conference (PR Newswire)
02.03.22	Creative Medical Technology Appoints Sahil Nock as Chief Commercial Officer (PR Newswire)
22.02.22	Pre-market Movers: DWAC, SKYH, LLL, OCGN, ANGH… (RTTNews)
18.02.22	Pre-market Movers: NRGV, ROKU, RDFN, CELZ, SHAK… (RTTNews)
05.01.22	Pre-market Movers: MYNZ, WEJO, ANNX, ARAV, SENS… (RTTNews)
04.01.22	Pre-market Movers: IMMX, VALN, LQDA, OSAT, EKSO… (RTTNews)
03.01.22	Pre-market Movers: CELZ, AFI, BLCT, AGE, PTE… (RTTNews)
07.12.21	Pre-market Movers: BJDX, MDB, CELZ, ISIG, ACAD… (RTTNews)
03.12.21	Creative Medical Prices $16 Mln Public Offering At $4.13 (RTTNews)
03.12.21	Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market (PR Newswire)
09.11.21	Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market (PR Newswire)
12.10.21	Creative Medical Technology Holdings Reports Positive Data on ImmCelz™ Immunotherapy Product (PR Newswire)
01.10.21	Creative Medical Technology Holdings Files Provisional Patent on Novel Type 1 Diabetes Immunotherapy Using Exosomes from MyeloCelz™ Platform (PR Newswire)
16.09.21	Creative Medical Technology Holdings, Inc. Engages Established Contact Management Organization to Accelerate Adoption of CaverStem® (PR Newswire)
09.08.21	Creative Medical Technology Holdings Announces $3.8 Million Private Placement with Institutional Investors (PR Newswire)
20.07.21	Creative Medical Technology Holdings Announces MyeloCelz™ The Company's Second Regenerative Immunotherapy Product (PR Newswire)
22.06.21	Creative Medical Technology Holdings Recruits Renowned Stem Cell Clinical Trials Expert to Hyper-Accelerate FDA Clearance (PR Newswire)
17.06.21	Creative Medical Technology Holdings To Present ImmCelz® Subsidiary At World Stem Cell Conference (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Creative Medical Technology Holdings Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten